First Clinical Trial Results of Xcellerex Inactivated Vaccine Against Yellow Fever Published in New England Journal of Medicine

technology. Based in Marlborough, Massachusetts, Xcellerex is backed by an experienced management team and top-tier venture investors including Kleiner Perkins Caufield & Byers, VantagePoint Venture Partners and SCG Capital. For more information, please...